Literature DB >> 15452231

Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation.

Jian-Hong Deng1, Yan-Jin Zhang, Xin-Ping Wang, Shou-Jiang Gao.   

Abstract

Defective viruses often have pivotal roles in virus-induced diseases. Although Kaposi's sarcoma-associated herpesvirus (KSHV) is etiologically associated with Kaposi's sarcoma (KS) and primary effusion lymphoma (PEL), defective KSHV has not been reported. Using differential genetic screening methods, we show that defective KSHV is present in KS tumors and PEL cell lines. To investigate the role of defective viruses in KSHV-induced pathogenesis, we isolated and characterized a lytic replication-defective KSHV, KV-1, containing an 82-kb genomic deletion of solely lytic genes. Cells harboring KV-1 escaped G(0)/G(1) apoptosis induced by spontaneous lytic replication occurred in cells infected with regular KSHV but maintained efficient latent replication. Consequently, KV-1-infected cells had phenotypes of enhanced cell proliferation and transformation potentials. Importantly, KV-1 was packaged as infectious virions by using regular KSHV as helpers, and KV-1-like variants were detected in cultures of two of five KSHV cell lines and 1 of 18 KS tumors. These results point to a potential role for defective viruses in the regulation of KSHV infection and malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452231      PMCID: PMC521843          DOI: 10.1128/JVI.78.20.11108-11120.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  80 in total

1.  Oncogenic transformation by equine herpesviruses (EHV). I. Properties of hamster embryo cells transformed by ultraviolet-irradiated EHV-1.

Authors:  R A Robinson; B E Henry; R G Duff; D J O'Callaghan
Journal:  Virology       Date:  1980-03       Impact factor: 3.616

Review 2.  Studies of defective herpes simplex viruses.

Authors:  N Frenkel; H Locker; D A Vlazny
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

3.  Severe immunodeficiency disease induced by a defective murine leukaemia virus.

Authors:  D C Aziz; Z Hanna; P Jolicoeur
Journal:  Nature       Date:  1989-04-06       Impact factor: 49.962

4.  Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification.

Authors:  G J Demmler; G J Buffone; C M Schimbor; R A May
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

5.  Oncogenic transformation by by equine herpesviruses. II. Coestablishment of persistent infection and oncogenic transformation of hamster embryo cells by equine herpesvirus type 1 preparations enriched for defective interfering particles.

Authors:  R A Robinson; R B Vance; D J O'Callaghan
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

6.  Isolation of 16L virus: a rapidly transforming sarcoma virus from an avian leukosis virus-induced sarcoma.

Authors:  B G Neel; L H Wang; B Mathey-Prevot; T Hanafusa; H Hanafusa; W S Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

7.  Expression of viral RNA in Friend virus-induced erythroleukemia cells.

Authors:  A S Berkower; F Lilly; R Soeiro
Journal:  Cell       Date:  1980-03       Impact factor: 41.582

8.  Chronic production of defective-interfering particles by hamster embryo cultures of herpesvirus persistently infected and oncogenically transformed cells.

Authors:  S A Dauenhauer; R A Robinson; D J O'Callaghan
Journal:  J Gen Virol       Date:  1982-05       Impact factor: 3.891

9.  In vitro transformation of mouse bone marrow cells by the polycythemic strain of Friend leukemia virus.

Authors:  R Revoltella; L Bertolini; C Friend
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

10.  Clonal analysis of early and late stages of erythroleukemia induced by molecular clones of integrated spleen focus-forming virus.

Authors:  Y Yamamoto; C L Gamble; S P Clark; A Joyner; T Shibuya; M E MacDonald; D Mager; A Bernstein; T W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

View more
  12 in total

1.  Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells.

Authors:  Seung Min Yoo; Fu-Chun Zhou; Feng-Chun Ye; Hong-Yi Pan; Shou-Jiang Gao
Journal:  Virology       Date:  2005-09-08       Impact factor: 3.616

Review 2.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

Review 3.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

4.  Biological and genotypic properties of defective interfering particles of equine herpesvirus 1 that mediate persistent infection.

Authors:  Paul D Ebner; Seong K Kim; Dennis J O'Callaghan
Journal:  Virology       Date:  2008-09-20       Impact factor: 3.616

5.  Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.

Authors:  Qiuhua Li; Meilan He; Fuchun Zhou; Fengchun Ye; Shou-Jiang Gao
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

6.  Screening of the Human Kinome Identifies MSK1/2-CREB1 as an Essential Pathway Mediating Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication during Primary Infection.

Authors:  Fan Cheng; Tanvee Vinod Sawant; Ke Lan; Chun Lu; Jae U Jung; Shou-Jiang Gao
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

7.  Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency.

Authors:  Feng-Chun Ye; Fu-Chun Zhou; Jian-Ping Xie; Tao Kang; Whitney Greene; Kurt Kuhne; Xiu-Fen Lei; Qui-Hua Li; Shou-Jiang Gao
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

8.  In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.

Authors:  Agata D'Agostino Mutlu; Lucas E Cavallin; Loïc Vincent; Chiara Chiozzini; Pilar Eroles; Elda M Duran; Zahra Asgari; Andrea T Hooper; Krista M D La Perle; Chelsey Hilsher; Shou-Jiang Gao; Dirk P Dittmer; Shahin Rafii; Enrique A Mesri
Journal:  Cancer Cell       Date:  2007-03       Impact factor: 31.743

9.  Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset.

Authors:  A Martin Lerner; Maria E Ariza; Marshall Williams; Leonard Jason; Safedin Beqaj; James T Fitzgerald; Stanley Lemeshow; Ronald Glaser
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

10.  A sequence-independent in vitro transposon-based strategy for efficient cloning of genomes of large DNA viruses as bacterial artificial chromosomes.

Authors:  Fuchun Zhou; Qiuhua Li; Shou-Jiang Gao
Journal:  Nucleic Acids Res       Date:  2008-11-06       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.